163 filings
S-8
DMAC
DiaMedica Therapeutics Inc
24 May 24
Registration of securities for employees
4:01pm
8-K
DMAC
DiaMedica Therapeutics Inc
23 May 24
Departure of Directors or Certain Officers
4:00pm
10-Q
2024 Q1
DMAC
DiaMedica Therapeutics Inc
Quarterly report
8 May 24
4:34pm
8-K
DMAC
DiaMedica Therapeutics Inc
8 May 24
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
4:30pm
8-K
DMAC
DiaMedica Therapeutics Inc
10 Apr 24
Departure of Directors or Certain Officers
4:36pm
EFFECT
r8oy eu00hbd9gzc6
10 Apr 24
Notice of effectiveness
12:15am
ARS
kfiq2 s55r
4 Apr 24
Annual report to shareholders
6:12am
DEFA14A
p2ek37ep6r ao9afh
4 Apr 24
Additional proxy soliciting materials
6:06am
8-K
ij41fo731z
19 Mar 24
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
4:16pm
8-K
do9 4vqgpsx
13 Nov 23
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
4:52pm
8-K
a6r0 3oxn0
5 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
lhfwl uqd01qq
14 Aug 23
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
4:25pm
424B3
5m6 nhlflrw9kp
10 Jul 23
Prospectus supplement
4:16pm
EFFECT
jrn0wvp0w u5dil
10 Jul 23
Notice of effectiveness
12:15am
CORRESP
onz7g
5 Jul 23
Correspondence with SEC
12:00am